Quality of Life for Pediatric Urolithiasis (Elattar)
Assessment of Health-Related Quality of Life for Pediatric Patients With Urinary Stone Disease.
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Ahmed R EL-Nahas, MD
- Phone Number: +201221136899
- Email: ar_el_nahas@yahoo.com
Study Locations
-
-
-
Mansoura, Egypt, 35516
- Recruiting
- Urology and nephrology center
-
Contact:
- M
-
Contact:
- Ahmed R EL-Nahas, MD
- Phone Number: 00201221136899
- Email: ar_el_nahas@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who had urinary stones
Exclusion Criteria:
- Patients presenting with obstructive uropathy or urosepsis.
- Recent (less than 4 weeks) surgical intervention for urinary stone disease.
- Indwelling urinary catheters or stents (urethral catheter, ureteral stents or nephrostomy tube).
- Associated mental illness or cognitive dysfunction.
- Associated chronic medical illness that may compromise QoL.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Patients
Pediatric patients who underwent treatment for utrollithiasis.
|
|
Control
Cross-matched group of healthy children.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The PedsQL questionnaire
Time Frame: 12 months
|
comparison of overall PedsQL score between pediatric urolithiasis patients and normal healthy age/sex matched population.
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ahmed R EL-Nahas, MD, Mansoura University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2278
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.